- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02808468
Brief Restructuring Intervention Following Trauma Exposure (BRITE)
February 4, 2025 updated by: Michele Bedard-Gilligan, University of Washington
Developing a Brief Early Cognitive Intervention for PTSD and Alcohol Misuse
The broad aim of this study is to develop and test a brief intervention that can be implemented in the immediate weeks following sexual assault to decrease likelihood of developing posttraumatic stress disorder (PTSD) or alcohol misuse.
The first phase of the study will enroll 6 women to complete a brief, cognitive therapy protocol and provide feedback on the intervention (open trial).
The second phase of the study will recruit 76 women to complete either the intervention (38 women) or assessment only (38 women) to test the effects of the intervention on both PTSD symptoms and alcohol use behavior as compared to natural recovery following assault.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Following sexual assault a substantial number of victims will go on to develop posttraumatic stress disorder (PTSD) or alcohol use disorders (AUD), and development of these disorders is costly to both the victim and society as a whole.
Intervening early, in the initial weeks following sexual assault, can provide victims with coping strategies that can decrease the likelihood of developing chronic symptoms.
Cognitive approaches for treating symptoms of PTSD have strong empirical support with chronic presentation of symptoms.
Less is known about effective strategies for intervening acutely following sexual assault.
This project is designed to adapt existing empirically supported cognitive treatment principles for both PTSD and AUD symptoms to be delivered acutely (within 10 weeks of assault) in a brief one session format followed by 4 weekly coaching calls.
The first 6 participants enrolled will receive the intervention and provide us with feedback on strengths and weaknesses of the protocol to help us improve it (Open Trial).
In the next phase, the pilot testing phase, the study will enroll 38 women to complete the one session intervention followed by 4 once per week coaching calls.
Participants will then be assessed again for symptoms of PTSD and alcohol use behavior at 3 month follow-up.
This brief intervention group will be compared at the 3 month follow-up to a group of 38 women who receive weekly symptom monitoring only.
Thus, this research aims to provide information on the efficacy of the intervention compared to the natural recovery process.
This research is significant in its potential to use a very brief and easy to access treatment to decrease the development of chronic psychopathology in a high risk group of women.
Study Type
Interventional
Enrollment (Actual)
57
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98195
- University of Washington
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Identifies as female
- Age > 18 years
- 2-10 weeks post sexual assault
PTSD symptoms related to recent sexual assault, specifically defined as a minimum of
1 reexperiencing, 1 avoidance, 2 negative alterations in mood/cognition, or 2 hyperarousal symptoms
- Drinking more than 3 drinks on one occasion in the last month and at least two reported negative consequences of alcohol use
- Capacity to provide informed consent
- English fluency
- No planned absences that they would be unable to complete 5 weeks of assessments and coaching calls
- Access to a telephone.
Exclusion Criteria:
- Acutely suicidal with intent/plan
- Exhibit current psychosis
- Previous non-response to an adequate trial (8 or more sessions) of Cognitive Processing Therapy (CPT)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Brief Cognitive Intervention
One in person session (90 minutes) of trauma focused cognitive therapy followed by 4 weekly coaching calls (20 minutes each) with the same study therapist
|
Cognitive strategies to help achieve balanced thinking around sexual assault and alcohol use
|
|
No Intervention: Assessment Only
Assessment session followed by weekly completion of assessment measures
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Posttraumatic Stress Disorder Symptom Scale- Interview Version (PSS-I)
Time Frame: 12 weeks
|
The Posttraumatic Stress Disorder Symptom Scale- Interview Version (PSS-I) assesses severity of symptoms of posttraumatic stress disorder (PTSD) as defined by the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) and is administered at baseline and 3 month follow up to assess change in PTSD symptoms.
The range for the scale is 0-80 with higher scores representing more severe PTSD symptoms.
|
12 weeks
|
|
Timeline Followback Heavy Episodic Drinking Episodes
Time Frame: 12 weeks
|
The Timeline Followback (TLFB) uses a calendar method with cued recall to assess frequency and quantity of alcoholic beverages consumed.
Quantity of drinks are reported per day.
Episodes of heavy episodic drinking (4+ drinks per occasion) are counted to calculate the number of HED episodes in the past month.
The minimum score possible is 0 for number of HED episodes in the past month and the maximum is 30 (count of days in past 30 days in which HED occurred).
Higher numbers indicate more heavy episodic drinking episodes.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Drinking Inventory of Consequences (DrInC)
Time Frame: 12 weeks
|
Total score of alcohol related negative consequences as reported on the self-report Drinking Inventory of Consequences (DrInC).
The total range of scores is 0-135 and higher scores indicate more negative consequences of alcohol use.
It is administered at baseline and 3-month follow-up to assess change in alcohol related consequences.
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michele Bedard-Gilligan, PhD, University of Washington
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2015
Primary Completion (Actual)
February 1, 2020
Study Completion (Actual)
February 1, 2020
Study Registration Dates
First Submitted
June 17, 2016
First Submitted That Met QC Criteria
June 17, 2016
First Posted (Estimated)
June 21, 2016
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 4, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00003232
- 1R34AA022966-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Use Disorders
-
University of Colorado, DenverUnknownAlcohol Use Disorders | Unhealthy Alcohol UseUnited States
-
Spark Biomedical, Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA); Baylor College... and other collaboratorsRecruitingSubstance Use Disorders | Alcohol Use Disorder | Alcohol Abuse | Substance Use Disorders Alcohol Use Withdrawal StateUnited States
-
Université du Québec à Trois-RivièresCompletedAlcohol Use, Unspecified | Alcohol Use Disorder, MildCanada
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of North Carolina, Chapel HillCompletedAlcohol Use Disorder, Mild | Alcohol Use Disorder, ModerateUnited States
-
Women's College HospitalRecruitingAlcohol; Harmful Use | Tobacco Use | Tobacco Use Cessation | Alcohol Use, UnspecifiedCanada
-
Indiana UniversityPatient-Centered Outcomes Research InstituteRecruitingAdolescent | Alcohol Use | Mild Alcohol Use Disorder | Mild Substance Use DisorderUnited States
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Substance Use Disorders | Alcohol Use Disorder (AUD)Germany
-
Washington State UniversityRecruitingNicotine Use Disorder | Alcohol Use Disorder (AUD)United States
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Methamphetamine-dependence | Substance Use Disorders | Cocaine Use Disorder | Alcohol Use Disorder (AUD) | Cannabis Use Disorder | Amphetamine Use DisorderGermany
Clinical Trials on Brief Cognitive Therapy
-
Massachusetts General HospitalNational Cancer Institute (NCI)CompletedDepression | Cancer | Anxiety | Unspecified Adult Solid Tumor, Protocol Specific | Cognitive Behavioral TherapyUnited States
-
Karolinska InstitutetRegion StockholmNot yet recruiting
-
The University of Texas Health Science Center at...59th Medical Wing; Brooke Army Medical Center; South Texas Veterans Health Care...CompletedCombat Disorders | Post-Traumatic Stress Disorders | Stress DisordersUnited States
-
Bath Spa University Academic Centre RAKCompletedDepression | Anxiety | Suicidal Ideation | Financial StressUnited Arab Emirates
-
Universidad de CórdobaUniversity Hospital Reina Sofia, Cordoba; State Research Agency, SpainNot yet recruitingGeneralized Anxiety Disorder | Anxiety | Somatoform Disorders | Generalized Anxiety | Emotional Disorders | Depression - Major Depressive Disorder | Somatization | Somatic Symptom Disorder (DSM-5)Spain
-
University of ManchesterCompleted
-
Florida State UniversityRecruiting
-
University of MinnesotaCompleted
-
Universidad Nacional Autonoma de HondurasUnknownAnxiety | Depressive Symptoms | Perceived Stress | Post Traumatic Stress SymptomsHonduras
-
Hartford HospitalOui Therapeutics, Inc.CompletedSuicidal and Self-injurious BehaviorUnited States